NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000
In Brief: General Murphy Resigns As Roswell Park Director; Penn.’s Richard Cooper Accepts Wisconsin Job
Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy
St. Jude Considers Relocating to Washington U.
ACS Cancer Response System Budget Request Total $185,140
ACCC/Oncology Economic Meeting to Examine DRGs, FCCs, Quality
Gallo To Give Scripps Symposium’s Schwartz Lecture
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - With five-year cancer survival at an all-time high, does this mean people are living longer?
- Blood Cancer United: A new name at the right moment
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - In The Headlines: Is early detection always good? Inside NCI’s MCD feasibility trial.
- Premarin’s 84-year hold on the market ends as FDA approves a generic version
Trade secret protections helped the hormone drug resist generic entry and outlast safety controversies—including link to cancer









